This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deleuze, V.
Right arrow Articles by Mathieu, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deleuze, V.
Right arrow Articles by Mathieu, D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2007, p. 2687-2697, Vol. 27, No. 7
0270-7306/07/$08.00+0     doi:10.1128/MCB.00493-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

TAL-1/SCL and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in Endothelial Cells{triangledown} ,{dagger}

Virginie Deleuze,1,2 Elias Chalhoub,1,2,§ Rawan El-Hajj,1,2 Christiane Dohet,1,2 Mikaël Le Clech,1,2,{ddagger} Pierre-Olivier Couraud,3,4 Philippe Huber,5 and Danièle Mathieu1,2*

Institut de Génétique Moléculaire de Montpellier CNRS, UMR5535, Montpellier, France,1 Université de Montpellier 2, Montpellier, France,2 Institut Cochin, INSERM/CNRS, Paris, France,3 Université Paris 5, Paris, France,4 CEA, INSERM, Grenoble, France5

Received 21 March 2006/ Returned for modification 20 May 2006/ Accepted 2 January 2007

The basic helix-loop-helix TAL-1/SCL essential for hematopoietic development is also required during vascular development for embryonic angiogenesis. We reported that TAL-1 acts positively on postnatal angiogenesis by stimulating endothelial morphogenesis. Here, we investigated the functional consequences of TAL-1 silencing in human primary endothelial cells. We found that TAL-1 knockdown caused the inhibition of in vitro tubulomorphogenesis, which was associated with a dramatic reduction in vascular endothelial cadherin (VE-cadherin) at intercellular junctions. Consistently, silencing of TAL-1 as well as of its cofactors E47 and LMO2 down-regulated VE-cadherin at both the mRNA and the protein level. Endogenous VE-cadherin transcription could be activated in nonendothelial HEK-293 cells by the sole concomitant ectopic expression of TAL-1, E47, and LMO2. Transient transfections in human primary endothelial cells derived from umbilical vein (HUVECs) demonstrated that VE-cadherin promoter activity was dependent on the integrity of a specialized E-box associated with a GATA motif and was maximal with the coexpression of the different components of the TAL-1 complex. Finally, chromatin immunoprecipitation assays showed that TAL-1 and its cofactors occupied the VE-cadherin promoter in HUVECs. Together, these data identify VE-cadherin as a bona fide target gene of the TAL-1 complex in the endothelial lineage, providing a first clue to TAL-1 function in angiogenesis.


* Corresponding author. Mailing address: Institut de Génétique Moléculaire de Montpellier CNRS, UMR5535, Montpellier, France. Phone: 33 467 613 655. Fax: 33 467 040 231. E-mail: daniele.mathieu{at}igmm.cnrs.fr.

{triangledown} Published ahead of print on 22 January 2007.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

V. Deleuze and E. Chalhoub contributed equally to the work.

§ Present address: University of Beirut, Beirut, Lebanon.

{ddagger} Present address: Max Planck Institute for Biochemistry, 82152 Martinsried, Germany.


Molecular and Cellular Biology, April 2007, p. 2687-2697, Vol. 27, No. 7
0270-7306/07/$08.00+0     doi:10.1128/MCB.00493-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Terme, J.-M., Lhermitte, L., Asnafi, V., Jalinot, P. (2009). TGF-{beta} induces degradation of TAL1/SCL by the ubiquitin-proteasome pathway through AKT-mediated phosphorylation. Blood 113: 6695-6698 [Abstract] [Full Text]  
  • Gratzinger, D., Zhao, S., West, R., Rouse, R. V., Vogel, H., Gil, E. C., Levy, R., Lossos, I. S., Natkunam, Y. (2009). The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities. Am J Clin Pathol 131: 264-278 [Abstract] [Full Text]  
  • Tanaka, A., Itoh, F., Itoh, S., Kato, M. (2009). TAL1/SCL Relieves the E2-2-Mediated Repression of VEGFR2 Promoter Activity. J Biochem 145: 129-135 [Abstract] [Full Text]  
  • Terme, J.-M., Wencker, M., Favre-Bonvin, A., Bex, F., Gazzolo, L., Duc Dodon, M., Jalinot, P. (2008). Cross Talk between Expression of the Human T-Cell Leukemia Virus Type 1 Tax Transactivator and the Oncogenic bHLH Transcription Factor TAL1. J. Virol. 82: 7913-7922 [Abstract] [Full Text]  
  • Zenvirt, S., Nevo-Caspi, Y., Rencus-Lazar, S., Segal, D. (2008). Drosophila LIM-Only Is a Positive Regulator of Transcription During Thoracic Bristle Development. Genetics 179: 1989-1999 [Abstract] [Full Text]  
  • Rodrigues, C. O., Nerlick, S. T., White, E. L., Cleveland, J. L., King, M. L. (2008). A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development. Development 135: 1903-1911 [Abstract] [Full Text]  
  • Birdsey, G. M., Dryden, N. H., Amsellem, V., Gebhardt, F., Sahnan, K., Haskard, D. O., Dejana, E., Mason, J. C., Randi, A. M. (2008). Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 111: 3498-3506 [Abstract] [Full Text]  
  • Landry, J.-R., Kinston, S., Knezevic, K., de Bruijn, M. F.T.R., Wilson, N., Nottingham, W. T., Peitz, M., Edenhofer, F., Pimanda, J. E., Ottersbach, K., Gottgens, B. (2008). Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver. Blood 111: 3005-3014 [Abstract] [Full Text]